2023 Q1 Form 10-K Financial Statement

#000135611523000004 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $14.87M $55.13M $134.3M
YoY Change 1.03% -36.64% 41.19%
Cost Of Revenue $3.912M $7.425M $18.57M
YoY Change -27.37% -0.4%
Gross Profit $10.95M $47.71M $115.8M
YoY Change -37.87% 51.33%
Gross Profit Margin 73.68% 86.53% 86.17%
Selling, General & Admin $3.596M $6.076M $6.261M
YoY Change 8599.89% 4220.02%
% of Gross Profit 32.83% 12.74% 5.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.524M $3.532M $7.175M
YoY Change
% of Gross Profit 32.17% 7.4% 6.2%
Operating Expenses $8.626M $16.93M $17.58M
YoY Change 2561.04% 1172.42%
Operating Profit $2.328M $30.77M $98.18M
YoY Change -59.59% 30.72%
Interest Expense $3.462M -$102.4M -$40.63M
YoY Change 971.83% -1303.18% -123.23%
% of Operating Profit 148.71% -332.67% -41.38%
Other Income/Expense, Net
YoY Change
Pretax Income -$18.72M -$71.60M $57.55M
YoY Change -184.57% -76.98%
Income Tax $800.0K $9.975M $12.00M
% Of Pretax Income 20.85%
Net Earnings -$19.52M -$83.88M $42.95M
YoY Change -133.5% -199.09% -82.82%
Net Earnings / Revenue -131.31% -152.15% 31.98%
Basic Earnings Per Share -$0.56
Diluted Earnings Per Share -$0.56 -$2.26 $1.16
COMMON SHARES
Basic Shares Outstanding 37.17M shares 37.17M
Diluted Shares Outstanding 37.17M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $736.2M $768.3M $13.40M
YoY Change 34226.58% 498.72%
Cash & Equivalents $8.348M $13.36M $13.40M
Short-Term Investments $727.9M $754.9M
Other Short-Term Assets $4.959M $6.441M $6.400M
YoY Change 1163.44% 1155.39%
Inventory
Prepaid Expenses
Receivables $7.211M $6.205M $6.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.52M $26.01M $26.00M
YoY Change 365.3% 365.19%
LONG-TERM ASSETS
Property, Plant & Equipment $267.8M $266.1M $266.1M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $69.85M $70.66M $825.6M
YoY Change -93.22% -20.77%
Other Assets $38.82M $37.54M $37.50M
YoY Change 8422.19% 8414.02%
Total Long-Term Assets $1.171B $1.197B $1.197B
YoY Change 14.82% 14.82%
TOTAL ASSETS
Total Short-Term Assets $20.52M $26.01M $26.00M
Total Long-Term Assets $1.171B $1.197B $1.197B
Total Assets $1.191B $1.223B $1.223B
YoY Change 16.69% 16.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.51M $13.87M $13.90M
YoY Change 1280.0% 1283.48%
Accrued Expenses $2.259M $1.369M $1.400M
YoY Change 449.03% 461.46%
Deferred Revenue
YoY Change
Short-Term Debt $422.0K $416.0K $400.0K
YoY Change -99.03% -99.07%
Long-Term Debt Due $8.000M $11.00M
YoY Change
Total Short-Term Liabilities $36.10M $27.76M $38.80M
YoY Change -48.17% -27.55%
LONG-TERM LIABILITIES
Long-Term Debt $157.9M $171.3M $160.3M
YoY Change
Other Long-Term Liabilities $5.656M $6.027M $6.000M
YoY Change
Total Long-Term Liabilities $163.6M $177.3M $166.3M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $36.10M $27.76M $38.80M
Total Long-Term Liabilities $163.6M $177.3M $166.3M
Total Liabilities $199.7M $205.1M $205.1M
YoY Change 282.92% 282.98%
SHAREHOLDERS EQUITY
Retained Earnings -$8.304M $17.95M
YoY Change -761.76%
Common Stock $37.00K $37.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $991.6M $1.018B $1.018B
YoY Change
Total Liabilities & Shareholders Equity $1.191B $1.223B $1.223B
YoY Change 16.69% 16.69%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$19.52M -$83.88M $42.95M
YoY Change -133.5% -199.09% -82.82%
Depreciation, Depletion And Amortization $3.524M $3.532M $7.175M
YoY Change
Cash From Operating Activities $505.0K $1.572M $67.77M
YoY Change -98.93% -75.52% 78.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $8.234M -$13.84M -$27.02M
YoY Change
Cash From Investing Activities $8.234M -$13.84M -$27.02M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$12.59M -16.38M -54.11M
YoY Change -7.59% 332.73% 21.89%
NET CHANGE
Cash From Operating Activities $505.0K 1.572M 67.77M
Cash From Investing Activities $8.234M -13.84M -27.02M
Cash From Financing Activities -$12.59M -16.38M -54.11M
Net Change In Cash -$3.848M -28.65M -13.36M
YoY Change -111.5% -1186.7% 111.25%
FREE CASH FLOW
Cash From Operating Activities $505.0K $1.572M $67.77M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001356115
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
534005152 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37171807 shares
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Auditor Name
AuditorName
KPMG, LLP
CY2022 dei Auditor Location
AuditorLocation
Dallas, Texas, United States
CY2022Q4 us-gaap Land
Land
47708000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
174469000 usd
CY2022Q4 us-gaap Rental Properties
RentalProperties
10979000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
39731000 usd
CY2022Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
354000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
754910000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
70656000 usd
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
67711000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13360000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
35289000 usd
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
1903000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6441000 usd
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4302000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2247000 usd
CY2022Q4 us-gaap Assets
Assets
1222902000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
144414000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
24250000 usd
CY2022Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
2624000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
13865000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10720000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
254000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1115000 usd
CY2022Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
416000 usd
CY2022Q4 us-gaap Advance Rent
AdvanceRent
1273000 usd
CY2022Q4 nxdt Intangible Lease Liabilities Net
IntangibleLeaseLiabilitiesNet
6027000 usd
CY2022Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
112000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
205070000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4800000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3359593 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3359593 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
3000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37171807 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37171807 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
999845000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17947000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1017832000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1222902000 usd
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1041985000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2238000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
440000 usd
CY2021Q4 nxdt Foreign Tax Reclaim Receivable
ForeignTaxReclaimReceivable
1250000 usd
CY2021Q4 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
192000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
277000 usd
CY2021Q4 nxdt Receivable For Company Shares Sold
ReceivableForCompanySharesSold
209000 usd
CY2021Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
913000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
510000 usd
CY2021Q4 us-gaap Assets
Assets
1048014000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
42500000 usd
CY2021Q4 srt Payables To Customers
PayablesToCustomers
110000 usd
CY2021Q4 us-gaap Investment Sold Not Yet Purchased At Fair Value
InvestmentSoldNotYetPurchasedAtFairValue
430000 usd
CY2021Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
9188000 usd
CY2021Q4 nxdt Investment Advisory Fees Payable
InvestmentAdvisoryFeesPayable
1005000 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
63000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
72000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
186000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
83252000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
911208000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
913920000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2712000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
911208000 usd
CY2021Q4 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
2157000 usd
CY2021 us-gaap Investment Sold Not Yet Purchased Sale Proceeds
InvestmentSoldNotYetPurchasedSaleProceeds
765000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
911208000 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37080000 shares
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.57
CY2021Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
1248000 usd
us-gaap Lease Income
LeaseIncome
10070000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4428000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
40600000 usd
us-gaap Other Income
OtherIncome
32000 usd
us-gaap Revenues
Revenues
55130000 usd
nxdt Property Operating Expenses
PropertyOperatingExpenses
3682000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
296000 usd
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
2695000 usd
nxdt Advisory And Administrative Fees
AdvisoryAndAdministrativeFees
5514000 usd
nxdt Conversion Expense
ConversionExpense
1615000 usd
us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
7175000 usd
us-gaap Costs And Expenses
CostsAndExpenses
24358000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
30772000 usd
us-gaap Interest Expense
InterestExpense
5759000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2257000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-92031000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2323000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-71598000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9975000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81573000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2310000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83883000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37172000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37172000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
79196000 usd
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
6279000 usd
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
2000000 usd
us-gaap Legal Fees
LegalFees
987000 usd
us-gaap Interest Expense
InterestExpense
696000 usd
nxdt Conversion Expense
ConversionExpense
471000 usd
us-gaap Professional Fees
ProfessionalFees
334000 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
185000 usd
us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
136000 usd
us-gaap Trustee Fees
TrusteeFees
109000 usd
nxdt Audit And Tax Preparation Fees
AuditAndTaxPreparationFees
77000 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
72000 usd
nxdt Pricing Fees
PricingFees
68000 usd
us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
56000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
322000 usd
us-gaap Costs And Expenses
CostsAndExpenses
11792000 usd
us-gaap Net Investment Income
NetInvestmentIncome
67404000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2310000 usd
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
61740000 usd
nxdt Period Increase Decrease In Net Assets Resulting From Operations
PeriodIncreaseDecreaseInNetAssetsResultingFromOperations
126834000 usd
CY2021 nxdt Securities Lending Income
SecuritiesLendingIncome
6000 usd
CY2021 nxdt Return Of Capital Reclassification
ReturnOfCapitalReclassification
11850000 usd
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
95136000 usd
CY2021 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
11094000 usd
CY2021 us-gaap Legal Fees
LegalFees
2206000 usd
CY2021 us-gaap Interest Expense
InterestExpense
2435000 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
558000 usd
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
145000 usd
CY2021 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
352000 usd
CY2021 us-gaap Trustee Fees
TrusteeFees
275000 usd
CY2021 nxdt Audit And Tax Preparation Fees
AuditAndTaxPreparationFees
124000 usd
CY2021 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
101000 usd
CY2021 nxdt Pricing Fees
PricingFees
279000 usd
CY2021 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
75000 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
990000 usd
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
75107000 usd
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
174903000 usd
CY2021 nxdt Period Increase Decrease In Net Assets Resulting From Operations
PeriodIncreaseDecreaseInNetAssetsResultingFromOperations
245455000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1112868000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83883000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Dividends Common Stock
DividendsCommonStock
11153000 usd
us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.68750
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2310000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1017832000 usd
us-gaap Net Investment Income
NetInvestmentIncome
67404000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2310000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
29146000 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
126834000 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
11139000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
11139000 usd
nxdt Investment Company Net Assets From Operations And Dividends Increase Decrease
InvestmentCompanyNetAssetsFromOperationsAndDividendsIncreaseDecrease
115695000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1288000 usd
nxdt Net Increase Decrease From Shares Transactions
NetIncreaseDecreaseFromSharesTransactions
2713000 usd
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
118408000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911208000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1029616000 usd
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
92067000 shares
nxdt Net Increase Decrease In Common Shares
NetIncreaseDecreaseInCommonShares
92067000 shares
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
75107000 usd
CY2021 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4555000 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-41721000 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
216624000 usd
CY2021 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
245455000 usd
CY2021 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
435000 usd
CY2021 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
21766000 usd
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
22201000 usd
CY2021 nxdt Investment Company Net Assets From Operations And Dividends Increase Decrease
InvestmentCompanyNetAssetsFromOperationsAndDividendsIncreaseDecrease
223254000 usd
CY2021 nxdt Capital Gains From Retirement Of Tendered Shares
CapitalGainsFromRetirementOfTenderedShares
47319000 usd
CY2021 nxdt Net Increase Decrease From Shares Transactions
NetIncreaseDecreaseFromSharesTransactions
-102871000 usd
CY2021 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
120383000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911208000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81573000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7175000 usd
nxdt Amortization Of Intangible Lease Liabilities
AmortizationOfIntangibleLeaseLiabilities
-743000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
67000 usd
nxdt Paid In Kind Interest Operating Activity
PaidInKindInterestOperatingActivity
2872000 usd
nxdt Realized Investment Gains Losses Including Noncash Amounts
RealizedInvestmentGainsLossesIncludingNoncashAmounts
-2323000 usd
nxdt Unrealized Gain Loss On Investments Including Noncash Amounts
UnrealizedGainLossOnInvestmentsIncludingNoncashAmounts
-92031000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2257000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2418000 usd
nxdt Payments For Life Settlement Premiums
PaymentsForLifeSettlementPremiums
2576000 usd
nxdt Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
-2247000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
10720000 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-2069000 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-606000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18105000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
14246000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
11276000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1382000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
5966000 usd
us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
26500000 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8700000 usd
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
7055000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14418000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
13250000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1181000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
9543000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
12500000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
14410000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
379000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2310000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11153000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19140000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2127000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50776000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48649000 usd
us-gaap Dividends And Interest Paid
DividendsAndInterestPaid
5284000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1501000 usd
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
3883000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
62510000 usd
us-gaap Net Income Loss
NetIncomeLoss
126834000 usd
nxdt Payments For Purchase Of Securities Sold Short Operating Activities
PaymentsForPurchaseOfSecuritiesSoldShortOperatingActivities
177000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
171000 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-741000 usd
us-gaap Increase Decrease In Client Funds Held
IncreaseDecreaseInClientFundsHeld
-192000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1583000 usd
nxdt Increase Decrease In Reclaim Receivable
IncreaseDecreaseInReclaimReceivable
-1250000 usd
nxdt Increase Decrease In Foreign Tax Reclaim Receivable
IncreaseDecreaseInForeignTaxReclaimReceivable
1274000 usd
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-1695000 usd
nxdt Increase Decrease In Payable For Admin Fees
IncreaseDecreaseInPayableForAdminFees
-11000 usd
nxdt Increase Decrease In Investment Advisory Fees
IncreaseDecreaseInInvestmentAdvisoryFees
49000 usd
us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
-110000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
82000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-150000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36336000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-26500000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
9714000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1288000 usd
nxdt Proceeds From Dividend Reinvestment
ProceedsFromDividendReinvestment
-44000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34970000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1366000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2678000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4044000 usd
nxdt Reinvestment Of Distributions
ReinvestmentOfDistributions
1425000 usd
us-gaap Interest Paid Net
InterestPaidNet
614000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
245455000 usd
CY2021 nxdt Payments For Purchase Of Securities Sold Short Operating Activities
PaymentsForPurchaseOfSecuritiesSoldShortOperatingActivities
414000 usd
CY2021 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
490000 usd
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-202000 usd
CY2021 us-gaap Increase Decrease In Client Funds Held
IncreaseDecreaseInClientFundsHeld
192000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-743000 usd
CY2021 nxdt Increase Decrease In Reclaim Receivable
IncreaseDecreaseInReclaimReceivable
1250000 usd
CY2021 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-5687000 usd
CY2021 nxdt Increase Decrease In Payable For Admin Fees
IncreaseDecreaseInPayableForAdminFees
2000 usd
CY2021 nxdt Audit Fees
AuditFees
-391000 usd
CY2021 nxdt Increase Decrease In Investment Advisory Fees
IncreaseDecreaseInInvestmentAdvisoryFees
103000 usd
CY2021 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
110000 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
60000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38066000 usd
CY2021 nxdt Proceeds Payments For Cumulative Preferred Shares
ProceedsPaymentsForCumulativePreferredShares
83252000 usd
CY2021 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-2500000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
20070000 usd
CY2021 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
105002000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-72000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44392000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6326000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9004000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2678000 usd
CY2021 nxdt Reinvestment Of Distributions
ReinvestmentOfDistributions
2131000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2371000 usd
CY2022 us-gaap Financial Designation Predecessor And Successor Fixed List
FinancialDesignationPredecessorAndSuccessorFixedList
Successor
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10700000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2200000 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1500000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2050000 usd
CY2022Q4 nxdt Deferred Tax Assets Capital Loss Carryforwards Utilized
DeferredTaxAssetsCapitalLossCarryforwardsUtilized
1924000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
590000 usd
CY2022Q4 nxdt Deferred Tax Assets Operating Loss Carryforwards Utilized
DeferredTaxAssetsOperatingLossCarryforwardsUtilized
119000 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
16677000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17274000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15027000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2247000 usd
CY2022Q2 us-gaap Land
Land
0 usd
CY2022Q3 us-gaap Land
Land
21208000 usd
CY2022Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
0 usd
CY2022Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
158304000 usd
CY2022Q2 us-gaap Rental Properties
RentalProperties
0 usd
CY2022Q3 us-gaap Rental Properties
RentalProperties
10979000 usd
CY2022Q2 us-gaap Development In Process
DevelopmentInProcess
0 usd
CY2022Q3 us-gaap Development In Process
DevelopmentInProcess
46052000 usd
CY2022Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
0 usd
CY2022Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
349000 usd
CY2022Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
0 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
916596000 usd
CY2022Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
236892000 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
1129544000 usd
CY2022Q3 us-gaap Marketable Securities
MarketableSecurities
804617000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
143264000 usd
CY2022Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
0 usd
CY2022Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
56440000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4044000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16136000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34640000 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
4849000 usd
CY2022Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
172000 usd
CY2022Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
2816000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3896000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6375000 usd
CY2022Q2 us-gaap Assets
Assets
1137656000 usd
CY2022Q3 us-gaap Assets
Assets
1306029000 usd
CY2022Q2 us-gaap Loans Payable
LoansPayable
0 usd
CY2022Q3 us-gaap Loans Payable
LoansPayable
145908000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
16000000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
23500000 usd
CY2022Q2 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
7492000 usd
CY2022Q3 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
7492000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1296000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3322000 usd
CY2022Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
0 usd
CY2022Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
2323000 usd
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 usd
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
639000 usd
CY2022Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
0 usd
CY2022Q3 us-gaap Security Deposit Liability
SecurityDepositLiability
434000 usd
CY2022Q2 us-gaap Advance Rent
AdvanceRent
0 usd
CY2022Q3 us-gaap Advance Rent
AdvanceRent
1845000 usd
CY2022Q2 nxdt Intangible Lease Liabilities Net
IntangibleLeaseLiabilitiesNet
0 usd
CY2022Q3 nxdt Intangible Lease Liabilities Net
IntangibleLeaseLiabilitiesNet
6770000 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
928000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
24788000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
193161000 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
83252000 usd
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4800000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3359593 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3359593 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
3000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37171807 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37171807 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
999845000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
112983000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
112983000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1029616000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1112868000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1137656000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1306029000 usd
CY2022Q4 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
4 property
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
155668000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13250000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 usd
CY2022Q4 us-gaap Long Term Debt Maturing In Years Four And Five
LongTermDebtMaturingInYearsFourAndFive
0 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
168918000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
70656000 usd
CY2022Q4 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
49863000 usd
CY2022Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
20793000 usd
CY2022 nxdt Equity Method Investment Share Of Earnings Loss
EquityMethodInvestmentShareOfEarningsLoss
501000 usd
CY2022Q4 nxdt Equity Method Investments And Other Investments At Fair Value
EquityMethodInvestmentsAndOtherInvestmentsAtFairValue
526096000 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
914183000 usd
nxdt Life Insurance Policies Matured Number
LifeInsurancePoliciesMaturedNumber
1 policy
nxdt Life Insurance Policies Matured Net Death Benefit
LifeInsurancePoliciesMaturedNetDeathBenefit
7000000 usd
nxdt Life Insurance Policies Matured Premiums
LifeInsurancePoliciesMaturedPremiums
2600000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts
LifeSettlementContractsFairValueMethodNumberOfContracts
28 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value
LifeSettlementContractsFairValueMethodFaceValue
142952000 usd
CY2022Q4 nxdt Life Settlement Contracts Fair Value Method Acquisition Cost
LifeSettlementContractsFairValueMethodAcquisitionCost
48132000 usd
CY2022Q4 nxdt Life Settlement Contracts Fair Value Method Premium Cost
LifeSettlementContractsFairValueMethodPremiumCost
4589000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Carrying Amount
LifeSettlementContractsFairValueMethodCarryingAmount
67711000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Next Rolling Twelve Months
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextRollingTwelveMonths
2 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing In Next Rolling Twelve Months
LifeSettlementContractsFairValueMethodFaceValueMaturingInNextRollingTwelveMonths
7000000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing In Next Rolling Twelve Months
LifeSettlementContractsFairValueMaturingInNextRollingTwelveMonths
5950000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Two
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearTwo
2 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Two
LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearTwo
7350000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing In Rolling Year Two
LifeSettlementContractsFairValueMaturingInRollingYearTwo
4774000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Three
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearThree
5 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Three
LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearThree
19061000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing In Rolling Year Three
LifeSettlementContractsFairValueMaturingInRollingYearThree
11393000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Four
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFour
8 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Four
LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFour
51351000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing In Rolling Year Four
LifeSettlementContractsFairValueMaturingInRollingYearFour
27648000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Five
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFive
3 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Five
LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFive
17100000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing In Rolling Year Five
LifeSettlementContractsFairValueMaturingInRollingYearFive
7978000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts Maturing After Rolling Year Five
LifeSettlementContractsFairValueMethodNumberOfContractsMaturingAfterRollingYearFive
8 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value Maturing After Rolling Year Five
LifeSettlementContractsFairValueMethodFaceValueMaturingAfterRollingYearFive
41090000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Maturing After Rolling Year Five
LifeSettlementContractsFairValueMaturingAfterRollingYearFive
9968000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Number Of Contracts
LifeSettlementContractsFairValueMethodNumberOfContracts
28 contract
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Face Value
LifeSettlementContractsFairValueMethodFaceValue
142952000 usd
CY2022Q4 us-gaap Life Settlement Contracts Fair Value Method Carrying Amount
LifeSettlementContractsFairValueMethodCarryingAmount
67711000 usd
CY2022Q4 nxdt Life Settlement Contracts Payable In Next Rolling12 Months
LifeSettlementContractsPayableInNextRolling12Months
5279000 usd
CY2022Q4 nxdt Life Settlement Contracts Payable In Rolling Year Two
LifeSettlementContractsPayableInRollingYearTwo
5769000 usd
CY2022Q4 nxdt Life Settlement Contracts Payable In Rolling Year Three
LifeSettlementContractsPayableInRollingYearThree
6295000 usd
CY2022Q4 nxdt Life Settlement Contracts Payable In Rolling Year Four
LifeSettlementContractsPayableInRollingYearFour
7011000 usd
CY2022Q4 nxdt Life Settlement Contracts Payable In Rolling Year Five
LifeSettlementContractsPayableInRollingYearFive
7675000 usd
nxdt Life Insurance Policies Purchased Number
LifeInsurancePoliciesPurchasedNumber
3 policy
nxdt Life Insurance Policies Purchased Face Value
LifeInsurancePoliciesPurchasedFaceValue
28000000 usd
nxdt Life Insurance Policies Purchased Payment
LifeInsurancePoliciesPurchasedPayment
8700000 usd
nxdt Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated
StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated
92067 shares
nxdt Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated
StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated
0 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37171807 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83883000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37171807 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37171807 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2022 nxdt Annual Advisory Fee Percent
AnnualAdvisoryFeePercent
0.0100
CY2022 nxdt Administrative Fee Percent
AdministrativeFeePercent
0.0020
nxdt Administrative And Advisory Fees Expense
AdministrativeAndAdvisoryFeesExpense
6300000 usd
CY2022 nxdt Annual Advisory Fee Percent
AnnualAdvisoryFeePercent
0.0100
CY2022 nxdt Administrative Fee Percent
AdministrativeFeePercent
0.0020
CY2022Q4 nxdt Advisory Agreement Maximum Monthly Fee
AdvisoryAgreementMaximumMonthlyFee
1000000 usd
CY2022Q4 nxdt Advisory Agreement Maximum Common Shares Issuable Percent
AdvisoryAgreementMaximumCommonSharesIssuablePercent
0.05
CY2022Q4 nxdt Advisory Agreement Maximum Voting Power Issuable Percent
AdvisoryAgreementMaximumVotingPowerIssuablePercent
0.05
CY2022Q4 nxdt Advisory Agreement Maximum Monthly Fee
AdvisoryAgreementMaximumMonthlyFee
1000000 usd
CY2022Q4 nxdt Advisory Agreement Threshold Trading Days
AdvisoryAgreementThresholdTradingDays
P10D
CY2022 nxdt Maximum Fee Percentage Of Managed Assets
MaximumFeePercentageOfManagedAssets
0.015
CY2022 nxdt Advisory Agreement Term
AdvisoryAgreementTerm
P3Y
CY2022 nxdt Advisory Agreement Additional Term
AdvisoryAgreementAdditionalTerm
P1Y
CY2022 nxdt Advisory Agreement Termination Threshold With Cause
AdvisoryAgreementTerminationThresholdWithCause
P30D
CY2022 nxdt Advisory Agreement Termination Threshold Without Cause
AdvisoryAgreementTerminationThresholdWithoutCause
P180D
CY2022 nxdt Advisory Agreement Termination Threshold Material Breach Of Contract
AdvisoryAgreementTerminationThresholdMaterialBreachOfContract
P30D
CY2022 nxdt Advisory Agreement Material Breach Of Contract Term
AdvisoryAgreementMaterialBreachOfContractTerm
P30D
CY2022 nxdt Termination Fee Calculation Threshold Period
TerminationFeeCalculationThresholdPeriod
P1Y
nxdt Administrative And Advisory Fees Expense
AdministrativeAndAdvisoryFeesExpense
5500000 usd
nxdt Deferred Expense To Comply With Cap
DeferredExpenseToComplyWithCap
1100000 usd
nxdt Maximum Fee Percentage Of Managed Assets
MaximumFeePercentageOfManagedAssets
0.015
CY2022Q4 nxdt Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
2100000 shares
CY2022Q4 nxdt Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
2100000 shares
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10334000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6310000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6002000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4687000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3872000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3320000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34525000 usd

Files In Submission

Name View Source Status
nxdt-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001356115-23-000004-index-headers.html Edgar Link pending
0001356115-23-000004-index.html Edgar Link pending
0001356115-23-000004.txt Edgar Link pending
0001356115-23-000004-xbrl.zip Edgar Link pending
a041nxdtnhfstatementofpref.htm Edgar Link pending
a1014nxdtcityplaceloanagre.htm Edgar Link pending
a1015guarantyofrecourseobl.htm Edgar Link pending
a1016guarantycompletion484.htm Edgar Link pending
a1017guarantyofrequiredequ.htm Edgar Link pending
a1018joinderagreementofnew.htm Edgar Link pending
a1019omnibusamendmentagree.htm Edgar Link pending
a1020nsp-arsponsorfundguar.htm Edgar Link pending
a1021nsp-nexpointcontribut.htm Edgar Link pending
a1022nsp-secondarllcagreem.htm Edgar Link pending
a1023nht-convertiblepromis.htm Edgar Link pending
a1024nht-convertiblepromis.htm Edgar Link pending
a105-formofrsuagreementtru.htm Edgar Link pending
a106-formofrsuagreementkey.htm Edgar Link pending
a211nxdt-ex211listofsubsid.htm Edgar Link pending
a231-consentofkpmg.htm Edgar Link pending
a232nxdt12312022_consentfo.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_01.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_0b.jpg Edgar Link pending
image_1.jpg Edgar Link pending
image_1b.jpg Edgar Link pending
image_2.jpg Edgar Link pending
image_2b.jpg Edgar Link pending
image_3a.jpg Edgar Link pending
image_3b.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nxdt-20221231.htm Edgar Link pending
nxdt-20221231.xsd Edgar Link pending
nxdt-20221231_g1.gif Edgar Link pending
nxdt-20221231_g2.jpg Edgar Link pending
nxdt-20221231_g3.jpg Edgar Link pending
nxdt-20221231_g4.jpg Edgar Link pending
nxdt-ex311sox302certificat.htm Edgar Link pending
nxdt-ex312sox302certificat.htm Edgar Link pending
nxdt-ex321sox906certificat.htm Edgar Link pending
nxdtdescriptionofsecuritie.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
nxdt-20221231_def.xml Edgar Link unprocessable
nxdt-20221231_lab.xml Edgar Link unprocessable
nxdt-20221231_pre.xml Edgar Link unprocessable
nxdt-20221231_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending